Modification of bacteraemia by specific antibodies and relation with mortality in a pneumococcal mouse sepsis model

Clinical and Experimental Immunology

Volumn 128, Issue 3, 2002, Pages 411-415

  Yuste, J ^a   Jado, I ^a   Gimenez M J ^b   Aguilar, L ^b   Molero, F ^a   Fenoll, A ^a   Casal, J ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b GLAXOSMITHKLINE   (Spain)

Author keywords

Animal model; Immunoprotection; Quantitative bacteraemia; S. pneumoniae

Indexed keywords

AGAR; CITRATE TRISODIUM; HYPERIMMUNE GLOBULIN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL COUNT; BACTERIAL VIRULENCE; BLOOD CULTURE; BLOOD SAMPLING; CONTROLLED STUDY; DEATH; DOSE RESPONSE; FEMALE; FOLLOW UP; IMMUNOTHERAPY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; TAIL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTEREMIA; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036281054     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01860.x     Document Type: Article

References (15)

1. Return to the past: The case for antibody-based therapy in infectious diseases
2. Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae
3. Streptococcus pneumoniae
4. Antibodies
5. Complement
6. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain. An update: 1990-96
7. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae
8. Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: The impact of serotypes, geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics
9. The mouse peritonitis/sepsis model
10. The mouse peritonitis model: Present and future use
11. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4
12. Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model
13. Prophylaxis and treatment of pneumococcal bacteremia by immune globulin intravenous in a mouse model
14. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B
15. Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats